October 26, 2020
2 min watch
Save
Evidence-based approach key to selecting anti-VEGF regimens
Healio spoke with Rishi P. Singh, MD, staff surgeon at Cleveland Clinic Cole Eye Institute, associate professor of ophthalmology at Lerner College of Medicine and Healio/OSN Board Member, about how he picks anti-VEGF regimens for his patients using an evidence-based approach.
Click here to watch the next video in the series on the greatest areas of unmet need in in anti-VEGF treatment for neovascular AMD and other retinal vascular diseases.
Published by:
Sources/Disclosures
Collapse
Disclosures:
Singh reports consulting for Alcon, Bausch + Lomb, Genentech, Novartis, Regeneron and Zeiss, and research grants from Aerie Pharmaceuticals, Apellis and Graybug.
Read more from Anti-VEGF Video Perspectives
View allRead more about